Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1. To consider, approve & take on record the Audited Standalone and Consolidated Financial Results of the Company along with the Auditor's Report thereon, for the Quarter and Year ended 31st March, 2026.2. To consider any other business with the permission of a Chairman of the Meeting.